Inhibitory effect of berberine on zeste homolog 2 (Ezh2) enhancement in human esophageal cell lines

Tropical Journal of Pharmaceutical Research

Volumn 14, Issue 9, 2015, Pages 1589-1595

  Chen, Si Ze ^a   Chen, Xue Mei ^b   Li, Yu Qi ^a   Zhang, Fan ^a   Yang, Shu ^a   Mo, Kai Lan ^a   Mo, Xian Yi ^a   Ding, Ying ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Anti invasive; Berberine; Cell proliferation; Histone methylation inhibitor; Human esophageal cancer

Indexed keywords

3 DEAZANEPLANOCIN A; BERBERINE; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ESOPHAGEAL CANCER CELL LINE; ESOPHAGUS CANCER; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

EID: 84943262925     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v14i9.7     Document Type: Article

References (29)

1. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343-349.
2. Richly H, Aloia L, Di-Croce L. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2011; 2: 204.
3. Sparmann A, Van LM. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 2006; 6: 846-856.
4. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002; 298: 1039-1043.
5. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan., Reubinoff BE, et al. Polycomb-mediated methylation on Lys27 of histone H3 premarks genes for de novo methylation in cancer. Nat. Genet. 2007; 39: 232-236.
6. Vire, E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439: 871-874.
7. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, Laird PW. Epigenetic stem cell signature in cancer. Nat. Genet. 2007; 39: 157-158.
8. Crea F, Hurt EM, Farrar WL. Clinical significance of Polycomb gene expression in brain tumors. Mol Cancer 2010; 9: 265-267.
9. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Nat Acad Sci USA 2003; 100: 11606-11611.
10. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh, D, Pienta KJ, Sewalt RG, Otte AP, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-629.
11. Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs 2009; 20: 757-769.
12. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 Cooperates berberine induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinogen 2009; 48, 24-37.
13. Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomed 2010; 17: 436-440.
14. Wang XN, Han X, Xu LN, Yin LH, Xu YW, Qi Y, Peng JY. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomed 2008; 15: 1062-1068.
15. Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, Wang W, Xie C, Meng J, Wang L. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8 F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. J Biol Chem 2009; 284: 27456-27466.
16. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009; 126: 5-17.
17. Liu SJ, Sun YM, Tian DF, He YC, Zeng L, He Y, Ling CQ, Sun SH. Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Brit J Cancer 2008; 98: 363-369.
18. Liu J, He C, Zhou K, Wang J, Kang JX. Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun 2009; 378: 174-178.
19. Lee J, Son MJ, Woolard K, Donin NM, Li A. Epigeneticmediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008; 13: 69-80.
20. Avilla E, Guarino V, Visciano C, Liotti F, Svelto M. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer. Cancer Res 2011; 71: 1792-1804.
21. Li Y, Ye X, Tan C, Hongo JA, Zha J. Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 2009; 28: 3442-3455.
22. Liu R, Gong M, Li X, Zhou Y, Gao W. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood 2010; 116: 297-305.
23. Rankin EB, Fuh KC. Taylor TE, Krieg AJ, Musser M. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. Cancer Res 2010; 70: 7570-7579.
24. Song X, Wang H, Logsdon CD, Rashid A, Fleming JB. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 2011; 117: 734-743.
25. Tsang CM, Lau EP, Di K, Cheung PY, Hau PM, Ching YP, Wong YC, Cheung AL, Wan TS, Tong Y, et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 2009; 24: 131-138.
26. Tan J, Yang X, Zhuang L, Jiang X, Chen W. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 2007; 21: 1050-1063.
27. Miranda TB, Cortez CC, Yoo CB, Liang G, Abe MDZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther 2009; 8: 1579-1588.
28. Fiskus W, Buckley K, Rao R, Mandawat A, Yang Y. Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated derepression of JunB and loss of survival of human acute leukemia cells. Cancer Biol Ther 2009; 8: 939-950.
29. Fiskus W, Pranpat M, Balasis M, Herger B, Rao R. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Mol Cancer Ther 2006; 5: 3096-3104.